Evaxion Biotech A/S

EVAX - CIK 0001828253

Market cap-

Rank-

SEC filings346

Evaxion Biotech A/S trades as EVAX. This page tracks Evaxion Biotech A/S through 346 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Total assets (latest FY)$28.41MFY 2025

Latest filings

Filing	Type	Filed
6-K	-	2026-05-12
6-K	-	2026-05-07
6-K	-	2026-05-04
6-K	-	2026-04-27
New insider ownership	3	2026-04-24
6-K	-	2026-04-22
6-K	-	2026-04-17
6-K	-	2026-04-17

Browse the full filing history (346 filings)

Similar companies

The largest companies sharing Evaxion Biotech A/S's SEC industry classification (biological products, (no diagnostic substances)).

AMGNAmgen Inc.$183.41 B EVAX vs AMGN

GILDGilead Sciences, Inc.$151.05 B EVAX vs GILD

ARGXargenx SE$53.35 B EVAX vs ARGX

RVMDRevolution Medicines, Inc.$30.65 B EVAX vs RVMD

BIIBBiogen Inc.$28.68 B EVAX vs BIIB

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.